BAY2757556 dose escalation
Research payments
$378,905
Through program year 2021, $378,905 in research payments was reported against BAY2757556 dose escalation, across 77 payments, paid by Bayer HealthCare Pharmaceuticals Inc..
- Paid by
- Bayer HealthCare Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $206,490 | 52 |
| 2020 | Research | $172,415 | 25 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Tejas Patil Aurora, CO Named on 22 payments
- Afshin Dowlati Cleveland, OH Named on 14 payments
- Devraj Basu Philadelphia, PA Named on 12 payments
- Marcia Brose Philadelphia, PA Named on 11 payments
- Kyaw Thein Portland, OR Named on 9 payments
- David Hong Houston, TX Named on 6 payments
- Anuradha Krishnamurthy Aurora, CO Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.